Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 504

1.

The cost-effectiveness of preventing AIDS-related opportunistic infections.

Freedberg KA, Scharfstein JA, Seage GR 3rd, Losina E, Weinstein MC, Craven DE, Paltiel AD.

JAMA. 1998 Jan 14;279(2):130-6. Erratum in: JAMA 1999 Jun 2;281(21):1989.

PMID:
9440663
2.
3.

Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.

Goldie SJ, Kaplan JE, Losina E, Weinstein MC, Paltiel AD, Seage GR 3rd, Craven DE, Kimmel AD, Zhang H, Cohen CJ, Freedberg KA.

Arch Intern Med. 2002 Apr 22;162(8):921-8.

PMID:
11966344
4.

The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS.

Scharfstein JA, Paltiel AD, Weinstein MC, Seage GR, Losina E, Craven DE, Freedberg KA.

Int J Technol Assess Health Care. 1999 Summer;15(3):531-47.

PMID:
10874380
5.

Prophylaxis for disseminated Mycobacterium avium complex (MAC) infection in patients with AIDS: a cost-effectiveness analysis.

Freedberg KA, Cohen CJ, Barber TW.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 1;15(4):275-82.

PMID:
9292586
6.

Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients.

Freedberg KA, Hardy WD, Holzman RS, Tosteson AN, Craven DE.

Med Decis Making. 1996 Jan-Mar;16(1):29-35.

PMID:
8717596
7.

Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis.

Yazdanpanah Y, Goldie SJ, Paltiel AD, Losina E, Coudeville L, Weinstein MC, Gerard Y, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KA.

Clin Infect Dis. 2003 Jan 1;36(1):86-96. Epub 2002 Dec 11.

PMID:
12491207
8.

Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort Study.

Sendi PP, Craig BA, Meier G, Pfluger D, Gafni A, Opravil M, Battegay M, Bucher HC.

J Antimicrob Chemother. 1999 Dec;44(6):811-7.

PMID:
10590283
9.

Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.

Sackoff J, McFarland J, Su S, Bryan E.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):387-92.

PMID:
9833748
10.

Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, Ward J.

MMWR CDC Surveill Summ. 1999 Apr 16;48(2):1-22.

PMID:
12412613
11.

Prophylaxis of opportunistic infections in adults and children with HIV infection.

[No authors listed]

AIDS Inst Newsl. 1995 Jun:1-12.

PMID:
11367408
12.

Preventing opportunistic infections.

Cheng B.

PI Perspect. 1995 May;(no 16):14-5.

PMID:
11362422
13.

State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards.

Johri M, David Paltiel A, Goldie SJ, Freedberg KA.

Med Care. 2002 May;40(5):429-41.

PMID:
11961477
14.

Cost-utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis.

Moore RD, Chaisson RE.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 1;16(1):15-21.

PMID:
9377120
15.

The cost effectiveness of combination antiretroviral therapy for HIV disease.

Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, Seage GR, Craven DE, Zhang H, Kimmel AD, Goldie SJ.

N Engl J Med. 2001 Mar 15;344(11):824-31.

16.
17.
18.

Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.

Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, Weinstein MC, Toure S, Smith HE, Kaplan JE, Freedberg KA; Global AIDS Policy Model Investigators.

AIDS. 2005 Aug 12;19(12):1299-308.

PMID:
16052085
19.

A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection.

Paltiel AD, Scharfstein JA, Seage GR 3rd, Losina E, Goldie SJ, Weinstein MC, Craven DE, Freedberg KA.

Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S93-105.

PMID:
9566470
20.

Supplemental Content

Support Center